As rising cases revive fears, the dangers of a lingering post-Covid syndrome that puts patients at risk long after recovery ...

A study by researchers from Johns Hopkins Medicine, the Johns Hopkins Bloomberg School of Public Health and The Johns Hopkins ...

The FDA is requiring COVID vaccine makers Pfizer and Moderna to update their warnings about the possible risk of myocarditis ...

Some trials are focusing on drugs that target the immune system, which is affected by different pathways to long covid.

It may not be the mythical fountain of youth, but the strength of the body's immune system, or immune resilience, could hold ...

“Individuals that experience long COVID report a constellation of symptoms, and these symptoms can be cognitive, they can be ...

Health care providers say they’re seeing more young patients suffer strokes — and the COVID-19 pandemic may be partly to ...